Physician's First Watch Archive

Medical news from NEJM Journal Watch

June 1, 2016

By Kelly Young

Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM

Use of methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) is associated with increased risk for arrhythmia — and potentially elevated risk for myocardial infarction — according to a self-controlled case series study in The BMJ.

Using a South Korean …

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM

Women with migraine face increased risk for cardiovascular events and CV mortality, according to a large prospective study in The BMJ.

In the Nurses' Health Study II, over 115,000 women …

By Kelly Young

Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM

The CDC offers new guidance for clinicians trying to interpret antibody test results for possible Zika infection.

When a patient with suspected Zika has …

By the Editors

NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:

NEJM Clinical Practice Center: Clinical Practice: After a gym workout, a …

May 31, 2016

By the Editors

Take a look at what the NEJM Journal Watch bloggers are talking about right now:

HIV and ID Observations: Like many clinicians, you …

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH

Public reporting of mortality rates in Medicare's Hospital Compare program did not improve mortality for three common conditions, an Annals of Internal Medicine study …

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH

The World Health Organization says there's "no public health justification" for canceling or postponing the 2016 Olympics in Rio de Janeiro, Brazil, the country most affected by the Zika outbreak. The statement …

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH

Escherichia coli resistant to colistin — the last-resort antibiotic used to treat carbapenem-resistant bacteria — has been identified in the U.S. for the first time, researchers report in Antimicrobial Agents and Chemotherapy. If colistin …

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH

The FDA has approved daclizumab (marketed as Zinbryta) to treat adults with relapsing multiple …

Pages